Happy Holidays to all. Please Note: There will be no meeting on New Year's Day

Finasteride does not increase risk of prostate cancer death

by Jim Barney on May 20, 2018

Share

The landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces mens’ risk of getting prostate cancer without increasing their risk of dying from the disease. Initial study findings suggested there may be a link between use of the drug and a more lethal form of prostate cancer, but long-term follow-up shows that is not true.

Read the article here.

{ 0 comments… add one now }

Previous post:

Next post: